Alloanergization of human T cells results in expansion of alloantigen-specific CD8+CD28- suppressor cells

American Journal of Transplantation

Volumn 14, Issue 2, 2014, Pages 305-318

  Barbon, C M ^a   Davies, J K ^a,b   Voskertchian, A ^a   Kelner, R H ^a   Brennan, L L ^a   Nadler, L M ^a,c,d   Guinan, E C ^a,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alloantigen specific; alloresponse; anergy; CD8 suppresser cell; costimulatory molecule blockade; immune tolerance; regulatory T cell (Treg)

Indexed keywords

ALLOANTIGEN; CD28 ANTIGEN;

ALLOTRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CLONAL ANERGY; FLOW CYTOMETRY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MONONUCLEAR CELL;

ANTIGENS, CD28; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONAL ANERGY; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; ISOANTIGENS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84895063188     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12575     Document Type: Article

References (43)

1. + cells. Semin Immunol 2006; 18: 78-88.
2. Pidala J, Anasetti C., Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse ? Haematologica 2010; 95: 660-665.
3. Bluestone JA., Mechanisms of tolerance. Immunol Rev 2011; 241: 5-19.
4. Tan P, Anasetti C, Hansen JA, et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993; 177: 165-173.
5. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869-1874.
6. Chen C, Nabavi N., In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1994; 1: 147-154.
7. Gribben JG, Guinan EC, Boussiotis VA, et al. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: A method to ameliorate graft-versus-host disease and extend the donor pool. Blood 1996; 87: 4887-4893.
8. Taylor PA, Noelle RJ, Blazar BR., CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311-1318.
9. Guinan EC, Boussiotis VA, Neuberg D, et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 1999; 340: 1704-1714.
10. Davies JK, Gribben JG, Brennan LL, Yuk D, Nadler LM, Guinan EC., Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: Results of 2 phase 1 studies. Blood 2008; 112: 2232-2241.
11. Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR., Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40: CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002; 99: 4601-4609.
12. Koenen HJ, Joosten I., Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness. Blood 2000; 95: 3153-3161.
13. Vermeiren J, Ceuppens JL, Van Ghelue M, et al. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity. J Immunol 2004; 172: 5371-5378.
14. Davies JK, Barbon CM, Voskertchian A, Nadler LM, Guinan EC., Ex vivo alloanergization with belatacept: A strategy to selectively modulate alloresponses after transplantation. Cell Transplant 2012; 21: 2047-2061.
15. Davies JK, Nadler LM, Guinan EC., Expansion of allospecific regulatory T cells after anergized, mismatched bone marrow transplantation. Sci Transl Med 2009; 1: 1ra3.
16. Taylor PA, Lees CJ, Blazar BR., The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493-3499.
17. - T regulatory cells. Clin Immunol 2009; 133: 22-26.
18. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics. Blood 2011; 117: 1061-1070.
19. Di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011; 117: 3921-3928.
20. + T cells that require antigen-specific activation for suppression. J Immunol 2003; 171: 6431-6441.
21. + tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 2004; 16: 1055-1068.
22. - T-suppressor cells in living donor liver transplant recipients. Hepatobiliary Pancreat Dis Int 2009; 8: 241-246.
23. El Essawy B, Putheti P, Gao W, Strom TB., Rapamycin generates graft-homing murine suppressor CD8(+) T cells that confer donor-specific graft protection. Cell Transplant 2011; 20: 1759-1769.
24. Tang Q, Adams JY, Tooley AJ, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006; 7: 83-92.
25. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ., Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats. Exp Neurol 2009; 216: 75-82.
26. + Treg cells are associated with immunological remission of lupus. J Immunol 2009; 183: 6346-6358.
27. + T cells. J Immunol 2009; 182: 2124-2130.
28. + T cells. J Immunol 2006; 177: 2775-2783.
29. Zhang Z, Zhang ZY, Schluesener HJ., Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J Immunol 2009; 183: 3081-3091.
30. - T cells. Int Immunol 1998; 10: 775-783.
31. + regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. J Immunol 2012; 189: 464-474.
32. Davies JK, Yuk D, Nadler LM, Guinan EC., Induction of alloanergy in human donor T cells without loss of pathogen or tumor immunity. Transplantation 2008; 86: 854-864.
33. Boussiotis VA, Freeman GJ, Taylor PA, et al. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat Med 2000; 6: 290-297.
34. Tzachanis D, Freeman GJ, Hirano N, et al. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2001; 2: 1174-1182.
35. Gershon RK, Kondo K., Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology 1970; 18: 723-737.
36. + effector-memory T cells with unique properties. J Immunol 2010; 185: 4470-4477.
37. + T lymphocytes in human peripheral blood increases with age. J Leukoc Biol 2008; 84: 1454-1461.
38. - T-suppressor cells in adult-to-adult living donor liver transplant recipients. Transplant Proc 2009; 41: 4229-4231.
39. + T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression. Am J Transplant 2008; 8: 338-347.
40. + CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control. J Immunol 2010; 184: 1690-1701.
41. - T cells express CD103 but not perforin. Hum Immunol 2009; 70: 96-100.
42. + regulatory T cells from naive precursors by CD40-activated B cells. Blood 2008; 112: 2554-2562.
43. Albert MH, Liu Y, Anasetti C, Yu XZ., Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. Eur J Immunol 2005; 35: 2598-2607.